AstraZeneca Rises on Report CEO Wants to Move Listing to US
Geplaatst: 01 jul 2025 21:54
AstraZeneca Plc’s shares rose after a report that Chief Executive Officer Pascal Soriot wants to move the British drugmaker’s stock listing to the US, in what would be a major blow to the UK’s equity markets.
Soriot has also discussed moving AstraZeneca’s domicile, the Times said, citing people familiar with the matter it didn’t identify. The executive is frustrated with the UK’s regulatory regime for drugs and is concerned the country is falling behind the US and China, it said.
“We do not comment on speculation,” AstraZeneca spokesman Tony Ho Wan Loke said by email.
https://archive.ph/te6oZ#selection-1567.0-1577.89
Soriot has also discussed moving AstraZeneca’s domicile, the Times said, citing people familiar with the matter it didn’t identify. The executive is frustrated with the UK’s regulatory regime for drugs and is concerned the country is falling behind the US and China, it said.
“We do not comment on speculation,” AstraZeneca spokesman Tony Ho Wan Loke said by email.
https://archive.ph/te6oZ#selection-1567.0-1577.89